Advancing American Freedom released the below statement after SCOTUS failed to reverse the FDA’s approval of mifepristone, the chemical abortion drug.
“In February, Advancing American Freedom, along with more than 30 fellow amici, filed an amicus brief with the Supreme Court arguing that since the FDA’s approval of the abortion drug mifepristone, the government has prioritized a political agenda over science and safety. Today, the Supreme Court failed to reverse the FDA’s unlawful approval in 2000 of mifepristone,” said AAF General Counsel J. Marc Wheat. “Finding that the physicians’ challenges to FDA had not suffered actual or imminent injury, the Court avoided an essential question: the political agenda-driven rather than science-supported review of the FDA’s initial approval and the Biden Administration’s inexplicable dropping of the safety measures required for the drug’s use. The road to the overturn of Roe v. Wade was long and marked by setbacks. The long struggle to protect women and the unborn against chemical abortion must go on in the same manner. AAF will continue to pursue legal advocacy that protects women and the unborn.”
You can read AAF’s initial amicus brief for the case here.
